Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time
Cromos Pharma CEO Dr Vlad Bogin is joined by Avance Clinical‘s CEO Yvonne Lungershausen to discuss some of the benefits available to biotechs by availing of a joint initiative that combines Australian tax benefits for clinical research with exceptional patient recruitment and retention in Eastern European markets. Read more here>>
This presentation was prepared January 2021 for activities around JP Morgan Healthcare Week. Please feel free to share this presentation with colleagues. If you have any queries please contact: email@example.com.